Hooke Laboratories, LLC is a U.S. contract research organization (CRO) specializing in non-clinical studies of inflammatory and autoimmune diseases. Known as a manufacturer of high-quality modeling kits, Hooke Laboratories, LLC supports drug discovery research around the world. This article describes in detail the company's service features, disease models, and study examples.
The company concentrates its resources in the area of inflammation and autoimmune diseases, rather than dealing with a broad range of general trials. In particular, the company has accumulated extensive knowledge and experience in models such as multiple sclerosis (EAE) and rheumatoid arthritis (CIA).
This professional background allows us to propose appropriate test systems tailored to the researcher's objectives and challenges. Support that takes into account complex pathomechanisms will help ensure smooth project progress.
For contract testing, we use Hooke Kits™, induction reagents that are quality-controlled and manufactured in-house. By controlling lot differences in the reagents used for testing, we have devised a way to reduce the factors that cause variation from experiment to experiment.
A system that does not rely on externally procured reagents is an important factor in the reproducibility of data. Evaluation under stable conditions provides an objective basis for decision-making in the validation of drug targets.
This is the standard model used in multiple sclerosis (MS) research.
Hooke Laboratories, LLC offers multiple EAE models using C57BL/6 and SJL mice. In addition to clinical scoring of neurological symptoms, we can provide detailed evaluation including histological analysis of the spinal cord and immune cells by flow cytometry. This is particularly suitable for drug efficacy evaluation as the incidence and severity of the disease is stable due to our in-house technology.
It is a representative arthritis model that shows pathology similar to human rheumatoid arthritis (RA).
Type II collagen is used to immunize mice (mainly DBA/1 strain) to induce joint swelling and bone destruction, and Hooke Laboratories' CIA model can be used to evaluate limb arthritis scores over time and to analyze joint tissue pathology (inflammatory cell infiltration, bone and cartilage destruction). It is widely used for screening anti-rheumatic drugs.
This study is designed to examine in detail the immune response after drug administration.
Using cells from mouse models of disease and immune mice, we evaluate antigen-specific T cell proliferative responses and cytokine production capacity. Using flow cytometry and ELISA, we will determine how the drug affected specific immune pathways. This analysis provides important data that will lead to the elucidation of the mechanism of action (MoA), not just the improvement of symptoms.
This service visually and quantitatively evaluates the degree of inflammation and tissue destruction.
We prepare and analyze pathology specimens of inflammatory cell infiltration and tissue damage (demyelination, bone destruction, etc.) in models of arthritis and encephalomyelitis. In addition to standard HE staining, immunohistochemical staining (IHC) can be used to detect specific proteins and cells. Reading and scoring by an experienced pathologist is an essential component of the reliability of drug efficacy evaluation.
Hooke Laboratories, LLC is a preclinical CRO based in Massachusetts, USA. Specializing in the construction of animal models of inflammatory and autoimmune diseases and the development and manufacture of related products, the company provides high-quality services to pharmaceutical companies and academic institutions worldwide.
| Address | 439 South Union Street, Lawrence, MA 01843, USA |
|---|---|
| Tel | +1 617 475 5114 |
| Website | https://hookelabs.com |
In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D.
In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening.
Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.